Moneycontrol
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Strides Pharma Science

Strides Pharma Science

BSE: 532531|NSE: STAR|ISIN: INE939A01011|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Apr 09, 11:42
332.25
7.85 (2.42%)
VOLUME 49,779
LIVE
NSE
Apr 09, 11:43
332.50
8.4 (2.59%)
VOLUME 366,368
News on Strides Pharma Science
Select Year: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Strides Shasun, Ajanta Pharma pass USFDA's ranitidine impurity test

6.01 pm | 06 Nov 2019 |  Source: Moneycontrol.com

The lab results also found that the NDMA impurity in ranitidine drugs sold by Dr Reddy’s and Aurobindo Pharma, Sanofi in beyond permissible limits....

GSK suspends Ranitidine distribution in India, regulators seek drug testing data from pharma cos

6.47 pm | 25 Sep 2019 |  Source: Moneycontrol.com

Sources within pharma industry told Moneycontrol that Dr Reddy’s and Saraca Laboratories are two big suppliers of the Ranitidine active pharmaceutic...

Strides re-enters injectable biz, to take controlling stake in Stelis Biopharma

7.36 pm | 20 Sep 2019 |  Source: Moneycontrol.com

The Strides board on September 20 approved an additional investment up to $40 million in Stelis, over a period of 24 months for the purpose....

Strides Pharma enters into JV with Sun Moral International

9.17 pm | 29 Jul 2019 |  Source: PTI

Both the companies will set up a JV company based in Hong Kong to be christened as Sihuan Strides HK, where SPG will own 49 per cent stake, Strides Ph...

Strides Pharma Consolidated June 2019 Net Sales at Rs 685.80 crore, up 3.37% Y-o-Y

5.45 pm | 29 Jul 2019 |  Source: Moneycontrol.com

NULL...

Strides Pharma Standalone June 2019 Net Sales at Rs 442.53 crore, up 26.52% Y-o-Y

4.52 pm | 29 Jul 2019 |  Source: Moneycontrol.com

NULL...

Strides Pharma gets EIR from US regulator for Bengaluru facility

6.35 pm | 23 Jul 2019 |  Source: PTI

'The company's formulations facility in Bengaluru, which was inspected by the United States Food and Drug Administration (USFDA) in May 2019, ...

Buy Strides Pharma; target of Rs 635: Motilal Oswal

5.01 pm | 13 May 2019 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Strides Pharma has recommended buy rating on the stock with a target price of Rs 635 in its research report dated May 11, ...

Strides Pharma Science Q4 profit after tax at Rs 43.81 cr

6.10 pm | 10 May 2019 |  Source: PTI

The company's consolidated revenue from operations stood at Rs 3,011.68 crore for 2018-19, against Rs 2,845.12 crore in the year-ago period....

Strides Pharma Consolidated March 2019 Net Sales at Rs 839.70 crore, up 26.43% Y-o-Y

3.15 pm | 10 May 2019 |  Source: Moneycontrol.com

NULL...

Strides Pharma Standalone March 2019 Net Sales at Rs 434.56 crore, up 11.71% Y-o-Y

2.51 pm | 10 May 2019 |  Source: Moneycontrol.com

NULL...

Strides arm and its partner get USFDA nod for hypokalemia treatment drug

11.59 am | 02 Apr 2019 |  Source: PTI

The United States Food and Drug Administration (USFDA) has approved the product in the strengths of 10 mEq (750 mg), 15 mEq (1,125 mg), and 20 mEq (1,...

Buy Strides Pharma Science; target of Rs 530: Geojit

3.48 pm | 18 Mar 2019 |  Source: Moneycontrol.com

Geojit is bullish on Strides Pharma Science has recommended buy rating on the stock with a target price of Rs 530 in its research report dated January...

Strides Pharma Science gets EIR for Bangalore facility

10.51 am | 06 Feb 2019 |  Source: PTI

"The company's formulations facility (KRSG Gardens) in Bangalore which was inspected by the US Food and Drug Administration (USFDA) in August 2018...

Buy Strides Pharma; target of Rs 590: Motilal Oswal

5.40 pm | 31 Jan 2019 |  Source: Moneycontrol.com

Motilal Oswal is bullish on Strides Pharma has recommended buy rating on the stock with a target price of Rs 590 in its research report dated January ...

Strides to ramp up sales in US, other regulated markets after Australia biz sale

7.57 pm | 30 Jan 2019 |  Source: Moneycontrol.com

Strides had a net debt of around Rs 1,820 crore as on December 31, 2018....

Strides to exit investment in Arrow for AUD 394 mn

5.55 pm | 29 Jan 2019 |  Source: PTI

The company's step-down subsidiary Strides Pharma Global Pte Ltd has approved the sale of its entire Australian business to the Arrow-Apotex merge...

Strides Pharma Consolidated December 2018 Net Sales at Rs 794.50 crore, up 6.07% Y-o-Y

1.27 pm | 29 Jan 2019 |  Source: Moneycontrol.com

NULL...

Strides Pharma Standalone December 2018 Net Sales at Rs 414.68 crore, up 39.22% Y-o-Y

1.27 pm | 29 Jan 2019 |  Source: Moneycontrol.com

NULL...

1
Quick Links for Strides Pharma Science
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.